Business
Veri Medtech (VRHI) Relaunches DosePop.com
Veri Medtech (VRHI) Relaunches DosePop.com.
About this update from Veri Medtech Holdings Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Veri Medtech (VRHI) Relaunches DosePop.com\r\n \r\n \r\n\r\n\r\nVeri Medtech (VRHI) Relaunches DosePop.com\r\n\r\n\r\n\r\n\r\n\r\nNEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Veri Medtech (Stock Ticker Symbol: “VRHI”) announced today the relaunch of its DosePop.com healthcare technology platform. For more information, please visit: www.DosePop.com. “Veri Medtech (VRHI) healthcare technology platform – DosePop.com serves as a powerful connector bringing patients and physicians together to enable and empower individuals to manage their well-being and quality of life from weight loss to hair loss and everything in between,\" said Sam Adetunji, CEO, Veri Medtech Holdings. About DosePop: DosePop, a wholly-owned subsidiary of publicly-traded Veri Medtech (Stock Ticker Symbol: “VRHI”), provides a one-stop healthcare technology platform for mental and physical health, all designed to empower you to take charge of your well-being. From weight loss solutions to anti-aging, our treatments are backed by science and administered by licensed professionals. For more information, please visit: www.DosePop.com. About Veri Medtech Holdings, Inc. (Stock Ticker Symbol: VRHI): Veri Medtech is a publicly-traded healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a strong integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models. With a commitment to innovation and patient-centric care, Veri MedTech continues to expand its services and reach, aiming to make personalized healthcare more accessible and effective for all. For more information, please visit: www.VeriMedTech.com. About Veriheal: Veriheal, a wholly-owned subsidiary of publicly-traded Veri Medtech Holdings – (Stock Ticker Sy...